Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.

Nuclear factor-kappa B (NF-kappaB)/Rel transcription factors play an important role in the inducible regulation of a variety of genes involved in the inflammatory and proliferative responses of cells. The present study was designed to elucidate the implication of NF-kappaB/Rel in the pathogenesis of atherosclerosis. Activation of the dimeric NF-kappaB complex is regulated at a posttranslational level and requires the release of the inhibitor protein IkappaB. The newly developed mAb alpha-p65mAb recognizes the IkappaB binding region on the p65 (RelA) DNA binding subunit and therefore selectively reacts with p65 in activated NF-kappaB. Using immunofluorescence and immunohistochemical techniques, activated NF-kappaB was detected in the fibrotic-thickened intima/media and atheromatous areas of the atherosclerotic lesion. Activation of NF-kappaB was identified in smooth muscle cells, macrophages, and endothelial cells. Little or no activated NF-kappaB was detected in vessels lacking atherosclerosis. Electrophoretic mobility shift assays and colocalization of activated NF-kappaB with NF-kappaB target gene expression suggest functional implications for this transcription factor in the atherosclerotic lesion. This study demonstrates the presence of activated NF-kappaB in human atherosclerotic tissue for the first time. Atherosclerosis, characterized by features of chronic inflammation and proliferative processes, may be a paradigm for the involvement of NF-kappaB/Rel in chronic inflammatory disease.

[1]  P. Baeuerle,et al.  Selective recognition of the activated form of transcription factor NF-kappa B by a monoclonal antibody. , 1995, Biological chemistry Hoppe-Seyler.

[2]  C. Ostberg,et al.  Fibronectin attachment activates the NF-kappa B p50/p65 heterodimer in fibroblasts and smooth muscle cells. , 1994, The Journal of biological chemistry.

[3]  Christian Kaltschmidt,et al.  Transcription factor NF-κB is activated in microglia during experimental autoimmune encephalomyelitis , 1994, Journal of Neuroimmunology.

[4]  Y. Yamashita,et al.  Involvement of NF-kappa B activation in thrombin-induced human vascular smooth muscle cell proliferation. , 1994, Biochemical and biophysical research communications.

[5]  W. Erl,et al.  Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-kappa B mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[6]  M. D. de Bruijn,et al.  Markers of mouse macrophage development detected by monoclonal antibodies. , 1994, Journal of immunological methods.

[7]  B. Beutler,et al.  An Evolutionary and Functional Approach to the TNF Receptor/Ligand Family , 1994, Annals of the New York Academy of Sciences.

[8]  J. Qiao,et al.  Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. , 1994, The Journal of clinical investigation.

[9]  H. Neumann,et al.  Constitutive NF-kappa B activity in neurons , 1994, Molecular and cellular biology.

[10]  F H Bach,et al.  NK-kappa B subunit-specific regulation of the I kappa B alpha promoter. , 1994, The Journal of biological chemistry.

[11]  R. Terkeltaub,et al.  Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[12]  C. Glass,et al.  Combinatorial interactions between AP-1 and ets domain proteins contribute to the developmental regulation of the macrophage scavenger receptor gene , 1994, Molecular and cellular biology.

[13]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.

[14]  R. Terkeltaub,et al.  Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[15]  R. Alexander,et al.  Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. , 1993, The Journal of clinical investigation.

[16]  J. Hiscott,et al.  Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop , 1993, Molecular and cellular biology.

[17]  F. Parhami,et al.  Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. , 1993, The Journal of clinical investigation.

[18]  T. Collins.  Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[19]  N. Mackman,et al.  Interferon-gamma inhibits macrophage apolipoprotein E production by posttranslational mechanisms. , 1993, The Journal of clinical investigation.

[20]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[21]  P. Baeuerle,et al.  Nuclear factor kappa B, a mediator of lipopolysaccharide effects. , 1993, Immunobiology.

[22]  V. Fuster,et al.  Coronary atherosclerosis : a multifactorial disease , 1993 .

[23]  M. Grilli,et al.  NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. , 1993, International review of cytology.

[24]  Amyj . Williams,et al.  Functional analysis of the human vascular cell adhesion molecule 1 promoter , 1992, The Journal of experimental medicine.

[25]  G. Rosen,et al.  Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). , 1992, The Journal of biological chemistry.

[26]  V. Fuster,et al.  A dilemma for the 1990s. Choosing appropriate experimental animal model for the prevention of restenosis. , 1992, Circulation.

[27]  J. Coucher,et al.  Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. , 1992, The American journal of pathology.

[28]  P. Libby,et al.  Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. , 1992, The American journal of pathology.

[29]  V. Ord,et al.  Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. , 1992, The American journal of pathology.

[30]  N. Mackman,et al.  Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites , 1991, The Journal of experimental medicine.

[31]  T. Annie,et al.  Inhibition of lipopolysaccharide-induced interleukin-1 beta mRNA expression in mouse macrophages by oxidized low density lipoprotein. , 1991, Journal of lipid research.

[32]  N. Mackman,et al.  Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide , 1991, Molecular and cellular biology.

[33]  P. Libby,et al.  Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[34]  N. Mackman,et al.  The Structural Biology of Expression and Function of Tissue Factor , 1991, Thrombosis and Haemostasis.

[35]  D. Steinberg,et al.  Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Cybulsky,et al.  Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.

[37]  D. Steinberg,et al.  Role of oxidised low density lipoprotein in atherogenesis. , 1993, British heart journal.

[38]  P. Baeuerle.  The inducible transcription activator NF-kappa B: regulation by distinct protein subunits. , 1991, Biochimica et biophysica acta.

[39]  P. Libby,et al.  Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[40]  M. Fishbein,et al.  Tumor necrosis factor gene expression in human vascular intimal smooth muscle cells detected by in situ hybridization. , 1990, The American journal of pathology.

[41]  G. Sonenshein,et al.  Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[42]  G. Chisolm,et al.  Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-alpha mRNA in stimulated murine peritoneal macrophages. , 1990, Journal of immunology.

[43]  A. Lusis,et al.  Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins , 1990, Nature.

[44]  R. Ross,et al.  Atherogenesis during low level hypercholesterolemia in the nonhuman primate. I. Fatty streak formation. , 1990, Arteriosclerosis.

[45]  H. Weiss,et al.  Cell constitution and characteristics of human atherosclerotic plaques selectively removed by percutaneous atherectomy. , 1989, Atherosclerosis.

[46]  Kathleen M. Smith,et al.  Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[47]  D. Baltimore,et al.  NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. , 1989, Cell.

[48]  D. Baltimore,et al.  I kappa B: a specific inhibitor of the NF-kappa B transcription factor. , 1988, Science.

[49]  M M Mesulam,et al.  A light and electron microscopic procedure for sequential double antigen localization using diaminobenzidine and benzidine dihydrochloride. , 1986, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[50]  A. Gown,et al.  Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. , 1986, The American journal of pathology.